Headquarters
KARL-FARKAS-GASSE 22, WIEN, Wien 1030, AT
WIEN, Wien, AT
EVELIQURE BIOTECHNOLOGIES GMBH
From the company
Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. It has developed a vaccine technology platform based on a live attenuated vaccine strain of the bacterium Shigella, engineered to induce broad protection against different species and serotypes, and expressing non-shigella derived antigens for protection against multiple pathogens. Its first-generation vaccine candidate, ShigETEC, target
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.